Literature DB >> 19769951

Putative antinociceptive action of nitric oxide in the caudal part of the spinal trigeminal nucleus during chronic carrageenan-induced arthritis in the rat temporomandibular joint.

Silvia A Tesser-Viscaíno1, Alexandre Denadai-Souza, Simone A Teixeira, Edílson Ervolino, Roelf J Cruz-Rizzolo, Soraia K Costa, Marcelo N Muscará, Cláudio A Casatti.   

Abstract

In order to investigate a putative role for nitric oxide (NO) in the central nociceptive processing following carrageenan-induced arthritis in the rat temporomandibular joint (TMJ), we analyzed the immunoreactivity, gene expression and activity of nitric oxide synthases (NOS) in the caudal part of the spinal trigeminal nucleus (Sp5C) during the acute (24 h), chronic (15 days) and chronic-active (14 days-24 h) arthritis. In addition, evaluation of head-withdrawal threshold was carried out in all phases of arthritis under chronic inhibition of nNOS with the selective inhibitor 7-nitroindazole (7-NI). Neurons with nNOS-like immunoreactivity (nNOS-LI) were concentrated mainly in the lamina II of the Sp5C, showing no significant statistical difference during arthritis. Only a discrete percentage of nNOS-LI neurons expressed Fos immunoreactivity. The mRNA expression for both nNOS and endothelial nitric oxide synthases (eNOS) presented no noticeable differences among the groups. No expression of inducible nitric oxide synthase (iNOS) was detected in the Sp5C by either immunohistochemistry or reverse-transcription polymerase chain reaction (RT-PCR). Ca(2+)-dependent NOS activity in the ipsilateral Sp5C was significantly higher (108.3+/-49.2%; P<0.01) in animals during the chronic arthritis. Interestingly, this increased activity was completely abolished 24 h later, in the chronic-active arthritis. Finally, head-withdrawal threshold decreased significantly in the chronic arthritis in animals under 7-NI chronic inhibition. In conclusion, nNOS immunoreactivity and mRNA expression are stable in the Sp5C during TMJ arthritis evolution, but its activity significantly increases in the chronic-phases supporting an antinociceptive role of the nNOS as evidenced by pain threshold experiment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19769951     DOI: 10.1016/j.brainres.2009.09.056

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Phenotypic alterations of neuropeptide Y and calcitonin gene-related peptide-containing neurons innervating the rat temporomandibular joint during carrageenan-induced arthritis.

Authors:  J P Damico; E Ervolino; K R Torres; D Sabino Batagello; R J Cruz-Rizzolo; C Aparecido Casatti; J Arruda Bauer
Journal:  Eur J Histochem       Date:  2012-10-01       Impact factor: 3.188

2.  Experimental model of zymosan-induced arthritis in the rat temporomandibular joint: role of nitric oxide and neutrophils.

Authors:  Hellíada Vasconcelos Chaves; Ronaldo de Albuquerque Ribeiro; André Mattos Brito de Souza; Antonio Alfredo Rodrigues e Silva; Antoniella Souza Gomes; Mariana Lima Vale; Mirna Marques Bezerra; Gerly Anne de Castro Brito
Journal:  J Biomed Biotechnol       Date:  2011-01-03

3.  Central release of nitric oxide mediates antinociception induced by aerobic exercise.

Authors:  G S Galdino; I D Duarte; A C Perez
Journal:  Braz J Med Biol Res       Date:  2014-12-19       Impact factor: 2.590

4.  Neuronal plasticity of trigeminal ganglia in mice following nerve injury.

Authors:  Randi Lynds; Chuang Lyu; Gong-Wei Lyu; Xie-Qi Shi; Annika Rosén; Kamal Mustafa; Tie-Jun Sten Shi
Journal:  J Pain Res       Date:  2017-02-09       Impact factor: 3.133

5.  Peripheral Purinergic Modulation in Pediatric Orofacial Inflammatory Pain Affects Brainstem Nitroxidergic System: A Translational Research.

Authors:  Elisa Borsani; Andrea Ballini; Barbara Buffoli; Lorenzo Lo Muzio; Marina Di Domenico; Mariarosaria Boccellino; Salvatore Scacco; Riccardo Nocini; Vittorio Dibello; Rita Rezzani; Stefania Cantore; Luigi Fabrizio Rodella; Michele Di Cosola
Journal:  Biomed Res Int       Date:  2022-03-11       Impact factor: 3.411

6.  Differential actions of indomethacin: clinical relevance in headache.

Authors:  Oliver Summ; Anna P Andreou; Simon Akerman; Philip R Holland; Jan Hoffmann; Peter J Goadsby
Journal:  Pain       Date:  2021-02-01       Impact factor: 7.926

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.